2.4.0.6 Html 171 326 1 true 37 0 false 4 false false R1.htm 0001 - Document - Document and Entity Information Sheet http://raptorpharma.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 0002 - Statement - Consolidated Balance Sheets Sheet http://raptorpharma.com/role/BalanceSheets Consolidated Balance Sheets false false R3.htm 0003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://raptorpharma.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) false false R4.htm 0004 - Statement - Consolidated Statements of Comprehensive Loss (Unaudited) Sheet http://raptorpharma.com/role/StatementsOfComprehensiveLoss Consolidated Statements of Comprehensive Loss (Unaudited) false false R5.htm 0005 - Statement - Consolidated Statements of Stockholders' Equity (Deficit) Sheet http://raptorpharma.com/role/StatementsOfStockholdersEquityDeficit Consolidated Statements of Stockholders' Equity (Deficit) false false R6.htm 0006 - Statement - Consolidated Statements of Cash Flows (Unaudited) Sheet http://raptorpharma.com/role/StatementsOfCashFlows Consolidated Statements of Cash Flows (Unaudited) false false R7.htm 0007 - Disclosure - 1. NATURE OF OPERATIONS AND BUSINESS RISKS Sheet http://raptorpharma.com/role/NatureOfOperationsAndBusinessRisks 1. NATURE OF OPERATIONS AND BUSINESS RISKS false false R8.htm 0008 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://raptorpharma.com/role/SummaryOfSignificantAccountingPolicies 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES false false R9.htm 0009 - Disclosure - 3. INTANGIBLE ASSETS AND GOODWILL Sheet http://raptorpharma.com/role/IntangibleAssetsAndGoodwill 3. INTANGIBLE ASSETS AND GOODWILL false false R10.htm 0010 - Disclosure - 4. FIXED ASSETS Sheet http://raptorpharma.com/role/FixedAssets 4. FIXED ASSETS false false R11.htm 0011 - Disclosure - 5. FAIR VALUE MEASUREMENT Sheet http://raptorpharma.com/role/FairValueMeasurement 5. FAIR VALUE MEASUREMENT false false R12.htm 0012 - Disclosure - 6. NOTE PAYABLE Sheet http://raptorpharma.com/role/NotePayable 6. NOTE PAYABLE false false R13.htm 0013 - Disclosure - 7. ACCRUED LIABILITIES Sheet http://raptorpharma.com/role/AccruedLiabilities 7. ACCRUED LIABILITIES false false R14.htm 0014 - Disclosure - 8. STOCK OPTION PLANS Sheet http://raptorpharma.com/role/StockOptionPlans 8. STOCK OPTION PLANS false false R15.htm 0016 - Disclosure - 10. ISSUANCE OF COMMON STOCK Sheet http://raptorpharma.com/role/IssuanceOfCommonStock 10. ISSUANCE OF COMMON STOCK false false R16.htm 0017 - Disclosure - 11. WARRANTS Sheet http://raptorpharma.com/role/Warrants 11. WARRANTS false false R17.htm 0018 - Disclosure - 12. COMMITMENTS AND CONTINGENCIES Sheet http://raptorpharma.com/role/CommitmentsAndContingencies 12. COMMITMENTS AND CONTINGENCIES false false R18.htm 0019 - Disclosure - 13. QUALIFYING THERAPEUTIC DISCOVERY PROJECT GRANT Sheet http://raptorpharma.com/role/QualifyingTherapeuticDiscoveryProjectGrant 13. QUALIFYING THERAPEUTIC DISCOVERY PROJECT GRANT false false R19.htm 0020 - Disclosure - 14. RELATED PARTY TRANSACTIONS Sheet http://raptorpharma.com/role/RelatedPartyTransactions 14. RELATED PARTY TRANSACTIONS false false R20.htm 0021 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://raptorpharma.com/role/SummaryOfSignificantAccountingPoliciesPolicies 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) false false R21.htm 0022 - Disclosure - 1. NATURE OF OPERATIONS AND BUSINESS RISKS (Tables) Sheet http://raptorpharma.com/role/NatureOfOperationsAndBusinessRisksTables 1. NATURE OF OPERATIONS AND BUSINESS RISKS (Tables) false false R22.htm 0023 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://raptorpharma.com/role/SummaryOfSignificantAccountingPoliciesTables 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) false false R23.htm 0024 - Disclosure - 3. INTANGIBLE ASSETS AND GOODWILL (Tables) Sheet http://raptorpharma.com/role/IntangibleAssetsAndGoodwillTables 3. INTANGIBLE ASSETS AND GOODWILL (Tables) false false R24.htm 0025 - Disclosure - 4. FIXED ASSETS (Tables) Sheet http://raptorpharma.com/role/FixedAssetsTables 4. FIXED ASSETS (Tables) false false R25.htm 0026 - Disclosure - 5. FAIR VALUE MEASUREMENT (Tables) Sheet http://raptorpharma.com/role/FairValueMeasurementTables 5. FAIR VALUE MEASUREMENT (Tables) false false R26.htm 0027 - Disclosure - 7. ACCRUED LIABILITIES (Tables) Sheet http://raptorpharma.com/role/AccruedLiabilitiesTables 7. ACCRUED LIABILITIES (Tables) false false R27.htm 0028 - Disclosure - 8. STOCK OPTION PLANS (Tables) Sheet http://raptorpharma.com/role/StockOptionPlansTables 8. STOCK OPTION PLANS (Tables) false false R28.htm 0030 - Disclosure - 10. ISSUANCE OF COMMON STOCK (Tables) Sheet http://raptorpharma.com/role/IssuanceOfCommonStockTables 10. ISSUANCE OF COMMON STOCK (Tables) false false R29.htm 0031 - Disclosure - 11. Warrants (Tables) Sheet http://raptorpharma.com/role/WarrantsTables 11. Warrants (Tables) false false R30.htm 0032 - Disclosure - 12. COMMITMENTS AND CONTINGENCIES (Tables) Sheet http://raptorpharma.com/role/CommitmentsAndContingenciesTables 12. COMMITMENTS AND CONTINGENCIES (Tables) false false R31.htm 0033 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) Sheet http://raptorpharma.com/role/SummaryOfSignificantAccountingPoliciesDetails1 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) false false R32.htm 0034 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 2) Sheet http://raptorpharma.com/role/SummaryOfSignificantAccountingPoliciesDetails2 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 2) false false R33.htm 0035 - Disclosure - 3. INTANGIBLE ASSETS AND GOODWILL (Details) Sheet http://raptorpharma.com/role/IntangibleAssetsAndGoodwillDetails 3. INTANGIBLE ASSETS AND GOODWILL (Details) false false R34.htm 0036 - Disclosure - 3. INTANGIBLE ASSETS AND GOODWILL (Details 1) Sheet http://raptorpharma.com/role/IntangibleAssetsAndGoodwillDetails1 3. INTANGIBLE ASSETS AND GOODWILL (Details 1) false false R35.htm 0037 - Disclosure - 4. FIXED ASSETS (Details) Sheet http://raptorpharma.com/role/FixedAssetsDetails 4. FIXED ASSETS (Details) false false R36.htm 0038 - Disclosure - 5. FAIR VALUE MEASUREMENT (Details) Sheet http://raptorpharma.com/role/FairValueMeasurementDetails 5. FAIR VALUE MEASUREMENT (Details) false false R37.htm 0039 - Disclosure - 5. FAIR VALUE MEASUREMENT (Details 1) Sheet http://raptorpharma.com/role/FairValueMeasurementDetails1 5. FAIR VALUE MEASUREMENT (Details 1) false false R38.htm 0040 - Disclosure - 7. ACCRUED LIABILITIES (Details) Sheet http://raptorpharma.com/role/AccruedLiabilitiesDetails 7. ACCRUED LIABILITIES (Details) false false R39.htm 0041 - Disclosure - 8. STOCK OPTION PLANS (Details) Sheet http://raptorpharma.com/role/StockOptionPlansDetails 8. STOCK OPTION PLANS (Details) false false R40.htm 0042 - Disclosure - 8. STOCK OPTION PLANS (Details 1) Sheet http://raptorpharma.com/role/StockOptionPlansDetails1 8. STOCK OPTION PLANS (Details 1) false false R41.htm 0043 - Disclosure - 8. STOCK OPTION PLANS (Details 2) Sheet http://raptorpharma.com/role/StockOptionPlansDetails2 8. STOCK OPTION PLANS (Details 2) false false R42.htm 0044 - Disclosure - 10. ISSUANCE OF COMMON STOCK (Details) Sheet http://raptorpharma.com/role/IssuanceOfCommonStockDetails 10. ISSUANCE OF COMMON STOCK (Details) false false R43.htm 0045 - Disclosure - 11. WARRANTS (Details) Sheet http://raptorpharma.com/role/WarrantsDetails 11. WARRANTS (Details) false false R44.htm 0046 - Disclosure - 11. WARRANTS (Details 1) Sheet http://raptorpharma.com/role/WarrantsDetails1 11. WARRANTS (Details 1) false false R45.htm 0047 - Disclosure - 12. COMMITMENTS AND CONTINGENCIES (Details) Sheet http://raptorpharma.com/role/CommitmentsAndContingenciesDetails 12. COMMITMENTS AND CONTINGENCIES (Details) false false R46.htm 0048 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://raptorpharma.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) false false R47.htm 0049 - Disclosure - 3. INTANGIBLE ASSETS AND GOODWILL (Details Narrative) Sheet http://raptorpharma.com/role/IntangibleAssetsAndGoodwillDetailsNarrative 3. INTANGIBLE ASSETS AND GOODWILL (Details Narrative) false false R48.htm 0050 - Disclosure - 4. FIXED ASSETS (Details Narrative) Sheet http://raptorpharma.com/role/FixedAssetsDetailsNarrative 4. FIXED ASSETS (Details Narrative) false false R49.htm 0051 - Disclosure - 8. STOCK OPTION PLANS (Details Narrative) Sheet http://raptorpharma.com/role/StockOptionPlansDetailsNarrative 8. STOCK OPTION PLANS (Details Narrative) false false R50.htm 0052 - Disclosure - 8. STOCK OPTION PLANS (Details Narrative 1) Sheet http://raptorpharma.com/role/StockOptionPlansDetailsNarrative1 8. STOCK OPTION PLANS (Details Narrative 1) false false R51.htm 0053 - Disclosure - 9. INCOME TAXES (Details Narrative) Sheet http://raptorpharma.com/role/IncomeTaxesDetailsNarrative 9. INCOME TAXES (Details Narrative) false false R52.htm 0054 - Disclosure - 10. ISSUANCE OF COMMON STOCK (Details Narrative) Sheet http://raptorpharma.com/role/IssuanceOfCommonStockDetailsNarrative 10. ISSUANCE OF COMMON STOCK (Details Narrative) false false R53.htm 0055 - Disclosure - 11. WARRANTS (Details Narrative) Sheet http://raptorpharma.com/role/WarrantsDetailsNarrative 11. WARRANTS (Details Narrative) false false All Reports Book All Reports Process Flow-Through: 0002 - Statement - Consolidated Balance Sheets Process Flow-Through: Removing column 'Aug. 31, 2010' Process Flow-Through: Removing column 'Aug. 31, 2009' Process Flow-Through: Removing column 'Aug. 31, 2008' Process Flow-Through: Removing column 'Aug. 31, 2007' Process Flow-Through: Removing column 'Aug. 31, 2006' Process Flow-Through: Removing column 'Sep. 07, 2005' Process Flow-Through: 0003 - Statement - Consolidated Balance Sheets (Parenthetical) Process Flow-Through: 0004 - Statement - Consolidated Statements of Comprehensive Loss (Unaudited) Process Flow-Through: Removing column '12 Months Ended Aug. 31, 2009' Process Flow-Through: Removing column '12 Months Ended Aug. 31, 2008' Process Flow-Through: Removing column '12 Months Ended Aug. 31, 2007' Process Flow-Through: Removing column '12 Months Ended Aug. 31, 2006' Process Flow-Through: 0006 - Statement - Consolidated Statements of Cash Flows (Unaudited) rptp-20121130.xml rptp-20121130.xsd rptp-20121130_cal.xml rptp-20121130_def.xml rptp-20121130_lab.xml rptp-20121130_pre.xml true true